However, the study found no difference in long-term outcomes for CABG vs. PCI among nondiabetic patients
Among patients with multivessel disease (MVD) and diabetes, coronary artery bypass surgery (CABG), showed lower rates of major adverse cardiovascular events (MACE) compared to percutaneous coronary intervention (PCI) in the long-term follow-up of the BEST trial.